MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » TAVI: Direct Flow taps ex-CoreValve chief Lemaitre | Personnel Moves

TAVI: Direct Flow taps ex-CoreValve chief Lemaitre | Personnel Moves

By

Direct Flow taps ex-CoreValve chief Lemaitre | Personnel Moves

The former Medtronic (NYSE:MDT) executive who led CoreValve to its $800 million acquisition is looking to compete with both of his former employers in the transcatheter aortic valve implant space.

Direct Flow Medical said today that it hired Daniel Lemaitre to be its president & CEO, replacing Bernard Lyons, who plans to retire effective immediately. Direct Flow said it also tapped David Boyle, a finance veteran from the pharmaceutical industry, to be its new CFO.

Lemaitre, at 1 time a healthcare analyst at Merrill Lynch and Cowen & Co., worked as Medtronic’s senior vice president for strategic planning & business development before moving to the CEO spot at CoreValve in 2008. Medtronic acquired CoreValve the next year. Lemaitre is chairman at  Smith & Nephew (FTSE:SN, NYSE:SNN) spinout Bioventus, is lead director at Endologix (NSDQ:ELGX) and on the board at Globus Medical (NYSE:GMED).

"Dan is the ideal person to help Direct Flow Medical realize its mission of becoming a true structural heart leader. Dan’s knowledge of the aortic valve space and the medical device landscape as a whole is unparalleled. His experience will be extraordinarily valuable as we become a major participant in the market. In addition, David Boyle will provide Dan with exceptionally strong financial stewardship as we build the company in the years ahead," Direct Flow chairman Paul LaViolette, himself a medtech vet of long standing, said in prepared remarks.

LaViolette also thanks Lyons for his 9 years in the corner office at the company.

"He took an innovative idea and made it real, generating excellent clinical results, securing critical financing, building a robust commercial organization in Europe and achieving strong regulatory momentum in the U.S. He built this company into 1 with tremendous growth potential and we are grateful for his contribution," LaViolette said.

"Direct Flow Medical has an innovative platform technology addressing one of the largest and fastest-growing markets in medical technology today – transcatheter aortic heart valve replacement, or TAVR – with the opportunity to address other structural heart diseases," Lemaitre added. "I am impressed with the unique benefits of the company’s technology platform and excited to be part of the team that will bring tremendous value to patients, physicians and investors."

In a separate release, Direct Flow said it named well-known heart valve expert Dr. Randolph Chitwood director of surgeon relations.

 Integra spinout SeaSpine’s new CEO is ex-NUVA COO Valentine

Integra LifeSciences (NSDQ:IART)
said ex-NuVasive Inc. (NSDQ:NUVA) CEO Keith Valentine is slated to be the CEO of its SeaSpine spinout once the transaction closes. SeaSpine acting CFO John Bostjancic won the permanent spot, the company said.
Read more

 Rivanna Medical names Williams CEO
Rivanna Medical, which makes an ultrasound device designed to guide spinal anesthesia procedures, said it named John Williams to be its new CEO, replacing chairman and now-CTO Will Mauldin in the corner office.
Read more

 Presbia names Strobel new sales veep
Presbia (NSDQ:LENS) said it named John Strobel to be its new vice president of sales. The ophthalmic implant maker’s former chief commercial officer, Jake Vander Zanden, left the company last month.
Read more

 Haemonetics promotes for COO, market prez spots

Haemonetics (NYSE:HAE) said it promoted Kent Davies to be its new chief operating officer and Byron Selman to president of global markets.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Respira Labs seeks FDA clearance for its wearable lung monitor
    Respira Labs recently announced that it has developed a wearable device that continuously assesses lung function without the need for traditional pulmonary function tests. Mountain View, California-based Respira Labs designed its Sylvee wearable initially to assess chronic obstructive pulmonary disease, COVID-19 and asthma patients. It is embedded with speakers and microphones that measure the change… […]
  • Owen Mumford starts work on new production center in U.K.
    Owen Mumford this week announced that it has started building its new production facility in Witney, Oxfordshire in the U.K. Owen Mumford’s new Witney facility will stand as a production site for the company’s recently launched, next-generation auto-injector Aidaptus. The company has decades of experience creating its own drug delivery, blood sampling and rapid diagnostic… […]
  • FDA’s Woodcock reassures about COVID-19 tests, vaccines under Omicron
    Acting FDA Commissioner Dr. Janet Woodcock thinks many COVID-19 tests will continue to work with the new Omicron variant — with information coming soon on vaccine efficacy. In a statement posted yesterday, Woodcock said she thought the agency is well-positioned to work with companies to address the potential impact of viral mutations on COVID-19 tests,… […]
  • Traco Power launches THM 60WI DC-DC converters
    Traco Power today announced it has launched its THM 60WI series of quarter brick DC-DC converters. The Baar, Switzerlad-based company designed the DC-DC converters with ultra-wide input ranges and safety approvals for medical and industrial applications. Traco Power’s THM 60WI series of converters consists of 12 models with 9-75 or 18-75 Vin ranges with single… […]
  • The 10 largest medtech employers of 2021 – and what their employees really think
    Employees of the 10 largest medtech employers are proud of working on life-saving products — with a greater appreciation for diversity and inclusion initiatives. That was one major takeaway as Medical Design & Outsourcing compiled some current and former employee reviews posted on Glassdoor. (Browse the online version of our Big 100 report.) Despite the pride, there was… […]
  • COVID-19 test makers say their products also detect Omicron
    Abbott, BD, Hologic, PerkinElmer, Thermo Fisher and Quidel are reassuring the public that their COVID-19 tests detect the Omicron variant. Discovered last week in South Africa, the new variant has enough mutations that it has raised concerns worldwide — even though it is still unknown for sure whether the mutations cause greater transmissibility or vaccine… […]
  • November 2021 Issue: The Big 100 – Medtech’s 100 Largest Players
      Browse the online version of the Big 100 An even larger medtech supply chain shock looms beyond the pandemic European approval ‘a big deal’ as Medtronic moves forward with Hugo surgical robot How medtech fared in the first waves of the pandemic People move the medtech industry forward The term “supply chain” brings to… […]
  • Could winged microchips monitor for airborne disease?
    Northwestern University engineers have created what they claim are the smallest-ever human-made flying structures — winged microchips that could monitor the air for disease and pollution. Engineering professor John Rogers and his team at Northwestern drew on inspiration from nature to create the microchips, which are the size of a grain of sand. The chips… […]
  • Smith+Nephew expands reach of its Cori handheld robotic system
    A year after Smith+Nephew (NYSE:SNN) launched its Cori handheld robotic system in the U.S.,  the ortho surgery system has launched globally. The British medtech giant has expanded Cori’s reach to Europe, Australia and New Zealand, India, and Canada (just announced today). The company yesterday said the system was now available for use in the U.K.’s National Health… […]
  • Elizabeth Holmes reportedly expresses remorse in criminal fraud trial
    Elizabeth Holmes reportedly revealed some regret over her handling of business as the ex-Theranos CEO took the stand again in a criminal fraud trial. Taking the stand yesterday for the third day of testimony in federal court in San Jose, California, Holmes was said to have shown remorse while still shifting some of the blame… […]
  • Supply chain, manufacturing issues slow Medtronic’s Hugo launch, ramp-up expected next fiscal year
    Medtronic (NYSE:MDT) Chair & CEO Geoff Martha confirmed that the launch of the Hugo surgical robot platform is off-schedule. Hugo received CE mark approval last month. The company is gearing up to conduct its FDA investigational device exemption (IDE) clinical trials in the U.S., with more on its stateside efforts still to come, Medtronic’s surgical robotics… […]

Leave a Reply